Absorica Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission. An International, Open-Label, Uncontrolled, Single-Arm, Multicenter, Phase 2 Trial
Condition:   Neuroblastoma Interventions:   Drug: Naxitamab;   Drug: GM-CSF;   Drug: Isotretinoin Sponsor:   Y-mAbs Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials

Combined Treatment With CO2 Laser and Isotretinoin for Acne Scars
Condition:   Acne Vulgaris Interventions:   Combination Product: Isotretinoin and CO2 laser;   Device: Co2 laser Sponsor:   Tel-Aviv Sourasky Medical Center Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2021 Category: Research Source Type: clinical trials